Last edition
News about
Biocon's Cranbury Facility in US Passes FDA Inspection, Supports Expansion Plans
Biocon’s inspection concluded with a single observation, which the company will address within the stipulated timeframe, and it is not expected to impact ongoing business operations
CCT, Kuehne+Nagel and Teva Prove Ocean Freight Viable for Temperature-Sensitive Pharmaceuticals
Cold Chain Technologies (CCT), a global leader in temperature-controlled packaging, has successfully completed a landmark project with logistics giant Kuehne + Nagel and Teva Pharmaceuticals, demonstrating the viability of ocean freight for high-value, temperature-sensitive pharmaceutical shipments.
Vasa Therapeutics Receives FDA IND Clearance to Advance Novel Small Molecule VS-041
Vasa Therapeutics plans to immediately initiate a phase-I (c) clinical trial in the US for participants with Heart Failure with Preserved Ejection Fraction (HFpEF).
<br />
BioCryst Strengthens Rare-Disease Portfolio with USD 700 Million Acquisition of Astria
Under the terms of the agreement, Astria shareholders will receive USD 8.55 per share in cash along with 0.59 BioCryst shares for each Astria share, representing a premium of about fifty-four percent over Astria’s previous closing price.
Balaji Amines Under Scrutiny for Producing Pharma-Grade Chemical Without Valid Licence
Indian authorities have accused Balaji Amines of manufacturing pharmaceutical-grade propylene glycol (PG) without possessing the necessary drug manufacturing licence, after certain test batches were reportedly found to be substandard.
EVOQ Therapeutics Receives USD 2 Million NIH Grant to Develop Therapies for Celiac Disease
The NIH award represents a significant endorsement of EVOQ's ground-breaking approach to harnessing the power of the immune system to treat and prevent autoimmune diseases.
Integral Molecular Launches Ready Reporter Virus Kit for 10x Faster Virus Neutralisation Testing
RRVs work by instantaneous detection of viral entry using a fluorescence-based readout. This rapid, safe and simple assay enables automatable workflows that can be performed in a standard laboratory setting.
WHO Issues Alert Over Contaminated Oral Liquid Medicines from India
The World Health Organization (WHO) has issued a Medical Product Alert following the identification of three substandard (contaminated) oral liquid medicines in India.
AMSBIO Unveils New Range of Cytokines Tailored for Organoid and Stem Cell Studies
AMS Biotechnology (Amsbio) has introduced a new range of over 30 independently developed and manufactured organoid culture-related cytokines for researchers working with stem cells and induced pluripotent stem cells (iPSCs).
Hikal Launches New High Potency API Laboratory at its Pune Integrated Innovation Centre
Hikal has inaugurated an advanced High Potency Active Pharmaceutical Ingredient (HPAPI) Laboratory at its Integrated Innovation Centre in Pune, further strengthening its end-to-end CDMO capabilities and enhancing its ability to safely develop, test and deliver highly potent compounds for the global pharmaceutical industry.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy